Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases. 1978

E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard

Bone marrow transplantation using an HLA-MLC-identical sibling is the most valuable treatment of severe aplastic anemia.2,6,7 Between November 1973 and March 1977, 25 consecutive patients have been treated by marrow transplantation in our unit. Nine patients are alive with complete hematologic restoration between 3 months and 3 years. The high mortality can be largely accounted for by marrow graft rejection (14 patients). Despite the small number of patients, we have tried to identify prognostic factors associated with marrow graft rejection. They are mainly the existence of anti-HLA antibodies, the sex difference, and the normal PHA and MLC response before grafting. After the graft, the disappearance of anti-HLA antibodies has a good prognostic value. The appearance of autolymphocytotoxins seems to correlate strongly either with rejection or graft-versus-host disease.

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
July 1988, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
September 1990, Nihon rinsho. Japanese journal of clinical medicine,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
March 2024, International journal of hematology,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
October 1991, Seminars in hematology,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
December 1976, Blood,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
September 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
November 1977, Diseases of the nervous system,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
July 1981, The Alabama journal of medical sciences,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
January 2000, Seminars in hematology,
E Gluckman, and A Devergie, and M Marty, and A Bussel, and J Rottemboúrg, and J Dausset, and J Bernard
January 1979, Acta haematologica,
Copied contents to your clipboard!